GlassScriptPhysician profile
Fareed A Sheikh
NPI 1871564039
$56,279.04
in general payments reported to CMS, 2019-2025
45 companies · $4,585 in 2025
The $4,585 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $9,252 · 2021: $5,546 · 2022: $3,776 · 2023: $6,984 · 2024: $3,982 · 2025: $4,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,352.68 |
| Travel and Lodging | $198.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21,145.37 | 2019-2025 | Cardiomems, Aveir, Amplatzer Amulet |
| Amarin Pharma, INC. | $17,778.44 | 2019-2020 | |
| Cvrx, INC. | $3,174.81 | 2019-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $1,993.98 | 2019-2025 | |
| Amgen INC. | $1,167.65 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $1,019.73 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Janssen Pharmaceuticals, INC | $846.01 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $822.25 | 2019-2025 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $750.92 | 2019-2024 | Lifevest |
| Edwards Lifesciences Corporation | $713.44 | 2021-2023 | Pascal |
| Abiomed | $646.67 | 2019-2023 | Impella |
| Getinge USA Sales, LLC | $582.62 | 2019-2024 | Cardiohelp |
| Shockwave Medical, INC | $484.03 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Respicardia, INC. | $439.40 | 2019-2021 | |
| Bridgebio Pharma, INC. | $435.02 | 2025 | Attruby |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $394.66 | 2024-2025 | Enroute Transcarotid Neuroprotection System, General - Crm_crm, Watchman Flx |
| Medtronic Vascular, INC. | $353.81 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $327.50 | 2019-2023 | Camzyos |
| Penumbra, INC. | $325.77 | 2019-2025 | Ruby Coil |
| Elutia, INC. | $260.46 | 2024-2025 | Ecm Patch,Pouch |
| Astrazeneca Pharmaceuticals LP | $249.85 | 2019-2025 | |
| Lexicon Pharmaceuticals, INC. | $201.15 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $196.82 | 2019-2024 | |
| Medtronic, INC. | $186.90 | 2021-2025 | Endurant Iis |
| Bayer Healthcare Pharmaceuticals INC. | $149.60 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $149.29 | 2023 | Gore Cardioform Septal Occluder |
| Pfizer INC. | $145.24 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $139.76 | 2019-2025 | Amvuttra |
| Vifor Pharma, INC. | $134.86 | 2019 | |
| Heartflow, INC. | $133.19 | 2021 | |
| Asahi Intecc USA, INC. | $125.43 | 2023 | Asahi Ptca Guide Wire |
| Cleerly, INC. | $115.02 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.41 | 2020-2024 | Jardiance |
| Livanova USA, INC. | $96.42 | 2021 | |
| Novo Nordisk INC | $90.85 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Scpharmaceuticals INC. | $84.71 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $71.17 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $49.62 | 2019-2022 | |
| Esperion Therapeutics, INC. | $45.78 | 2021-2025 | Nexletol |
| Impulse Dynamics (USA) INC. | $43.37 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $39.69 | 2021-2022 | |
| Irhythm Technologies, INC. | $19.31 | 2023 | Zio Xt Patch |
| Arbor Pharmaceuticals, INC. | $17.30 | 2019 | |
| Tactile Systems Technology INC | $15.56 | 2023 | Entre Plus, Flexitouch Plus |
| Baylis Medical Company INC | $14.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fareed Sheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.